Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Protara Therapeutics, Inc. (TARA) had Return on Equity of -13.43% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-21.67M |
|
-- |
|
-- |
|
$23.32M |
|
$-23.32M |
|
$1.66M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-21.67M |
|
$-23.32M |
|
$-23.70M |
|
61.01M |
|
61.01M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$146.15M |
|
$1.32M |
|
$29.94M |
|
$176.09M |
|
$13.32M |
|
-- |
|
$1.46M |
|
$14.78M |
|
$161.31M |
|
$161.31M |
|
$161.31M |
|
59.08M |
|
| Cash Flow Statement Financials | |
$-36.73M |
|
$3.03M |
|
$1.12M |
|
$50.40M |
|
$17.82M |
|
$-32.58M |
|
$2.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-37.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-13.43% |
-13.43% |
|
-12.30% |
|
-13.43% |
|
$2.73 |
|
$-0.61 |
|
$-0.60 |
|